Physicians examine the enduring effectiveness and key findings from the POETYK PSO-1 clinical trials, evaluating their impact on the evolving landscape of psoriasis treatment options.
Study Compares Dose Escalation with Biologics in Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls
Higher Risankizumab Adherence with New Injection Device